Alzheimer's Disease Trial, Recruiting NCT06962111 Sponsor: Arizona State University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06962111
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be at least 60 years old
  • You must be able to communicate in English or Spanish
  • You must currently live in the United States
  • You must be able to give your agreement to participate both by speaking and in writing (this can be done electronically or by mail)
  • You must show at least 2 out of 8 signs of memory or thinking changes on a short screening questionnaire called the AD8
  • You must either have a formal diagnosis of early-stage dementia or Alzheimer's-related condition, OR score within a certain range on a standard memory test — the exact range depends on your education level and whether you have a confirmed diagnosis (confirm with trial site)
  • You must be able to attend workshops online using the video app Zoom

Who may not be able to join:

  • You are unable to participate by phone or online video call
  • You do not wish to take part
  • You do not have enough time available to attend the training sessions
  • You do not have the basic computer skills needed to take part in online sessions
  • You do not have a reliable internet connection to join video calls
  • You have hearing difficulties or a vision impairment that would prevent you from fully participating

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr. Gomez-Morales, ASU

Phone: 602-543-6672

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Arizona State University
Registry
ClinicalTrials.gov
Start date
26 March 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Quality of Life in Alzheimer's Disease (QoL-AD); UCLA 3-item Loneliness Scale; Dementia Quality of Life (DQoL)- Positive and Negative Feelings Affect Scale; Center of Epidemiologic Studies-Depression short form (CES-D); Hopkins Symptoms Checklist - Anger Subscale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov